Table 1.
Groups |
BCL-2 expression
|
|||||
---|---|---|---|---|---|---|
- | +/- | + | ++ | +++ | Total | |
Control | 12 (34.3%) | 13 (37.1%) | 8 (22.9%) | 2 (5.7%) | 0 (.0%) | 35 (100.0%) |
Azelaic acid* | 7 (20.0%) | 10 (28.6%) | 12 (34.3%) | 5 (14.3%) | 1 (2.9%) | 35 (100.0%) |
Finasteride* | 7 (20.0%) | 7 (20.0%) | 14 (40.0%) | 6 (17.1%) | 1 (2.9%) | 35 (100.0%) |
*p < 0.05 compared to the control group